GO
Loading...

Eli Lilly and Co

More

  • Final Glance: Pharmaceuticals companies Monday, 20 Apr 2015 | 7:11 PM ET

    Baxter International Inc. rose$. 45 or. 6 percent, to $70.36. Bristol-Myers Squibb Co. rose$. 51 or. 8 percent, to $65.86. Eli Lilly& Co. fell$. 06 or. 1 percent, to $72.41.

  • Midday Glance: Pharmaceuticals companies Monday, 20 Apr 2015 | 1:17 PM ET

    Baxter International Inc. rose$. 56 or. 8 percent, to $70.47. Bristol-Myers Squibb Co. rose$. 56 or. 9 percent, to $65.91. Eli Lilly& Co. fell$. 10 or. 1 percent, to $72.38.

  • Early Glance: Pharmaceuticals companies Monday, 20 Apr 2015 | 10:38 AM ET

    Baxter International Inc. rose$. 34 or. 5 percent, to $70.25. Bristol-Myers Squibb Co. rose$. 28 or. 4 percent, to $65.63. Eli Lilly& Co. rose$. 38 or. 5 percent, to $72.85.

  • April 20- Eli Lilly and Co said its experimental drug, ixekizumab, reduced the signs and symptoms of active psoriatic arthritis in patients more than a placebo did in a late-stage trial. Up to 30 percent of psoriasis patients develop psoriatic arthritis, an inflammatory form of arthritis that can cause swelling, stiffness and pain in and around joints, according...

  • LILLY'S PSORIATIC ARTHRITIS DRUG SUCCEEDS IN LATE-STAGE STUDY@. April 20- Eli Lilly and Co said its experimental drug, ixekizumab, was more effective than a placebo in patients with active psoriatic arthritis, in a late-stage trial. Psoriatic arthritis is a progressive and chronic disease that can cause swelling, stiffness and pain in and around joints.

  • Earnings next test for stocks after market wipeout Monday, 20 Apr 2015 | 5:52 AM ET
    Traders work on the floor of the New York Stock Exchange.

    Stocks could chop around and rack up more losses in the week ahead, with the next wave of corporate earnings reports.

  • Final Glance: Pharmaceuticals companies Friday, 17 Apr 2015 | 6:03 PM ET

    Baxter International Inc. fell$. 24 or. 3 percent, to $69.91. Hospira fell$. 21 or. 2 percent, to $87.46. Johnson& Johnson fell$. 21 or. 2 percent, to $99.58.

  • Earnings next test for stocks after market wipeout Friday, 17 Apr 2015 | 4:29 PM ET
    Traders work on the floor of the New York Stock Exchange.

    Stocks could chop around and rack up more losses in the week ahead, with the next wave of corporate earnings reports.

  • Midday Glance: Pharmaceuticals companies Friday, 17 Apr 2015 | 1:17 PM ET

    Baxter International Inc. fell$. 23 or. 3 percent, to $69.92. Bristol-Myers Squibb Co. rose $1.84 or 2.9 percent, to $65.52. Eli Lilly& Co. fell$. 97 or 1.3 percent, to $72.52.

  • Early Glance: Pharmaceuticals companies Friday, 17 Apr 2015 | 10:57 AM ET

    Baxter International Inc. fell$. 23 or. 3 percent, to $69.92. Bristol-Myers Squibb Co. rose $1.68 or 2.6 percent, to $65.36. Johnson& Johnson fell$. 23 or. 2 percent, to $99.56.

  • Final Glance: Pharmaceuticals companies Thursday, 16 Apr 2015 | 6:03 PM ET

    Baxter International Inc. fell$. 05 or. 1 percent, to $70.15. Bristol-Myers Squibb Co. rose$. 25 or. 4 percent, to $63.68. Hospira fell$. 02 or percent, to $87.67.

  • Midday Glance: Pharmaceuticals companies Thursday, 16 Apr 2015 | 1:29 PM ET

    Baxter International Inc. fell$. 12 or. 2 percent, to $70.08. Bristol-Myers Squibb Co. rose$. 19 or. 3 percent, to $63.62. Eli Lilly& Co. fell$. 10 or. 1 percent, to $73.61.

  • Final Glance: Pharmaceuticals companies Wednesday, 15 Apr 2015 | 5:57 PM ET

    Baxter International Inc. rose$. 22 or. 3 percent, to $70.20. Bristol-Myers Squibb Co. fell$. 60 or. 9 percent, to $63.43. Eli Lilly& Co. rose$. 25 or. 3 percent, to $73.71.

  • Midday Glance: Pharmaceuticals companies Wednesday, 15 Apr 2015 | 2:34 PM ET

    Baxter International Inc. rose$. 48 or. 7 percent, to $70.46. Bristol-Myers Squibb Co. fell$. 27 or. 4 percent, to $63.76. Eli Lilly& Co. rose$. 19 or. 3 percent, to $73.65.

  • LONDON, April 15- Having seen off a hostile $118 billion bid launched a year ago by U.S. rival Pfizer, Anglo-Swedish company AstraZeneca is on the move-- quite literally. Chief Executive Pascal Soriot is making AstraZeneca more nimble as hopes build for its cancer pipeline, but he still has his work cut out to keep 2015 earnings above the floor needed to protect his...

  • Final Glance: Pharmaceuticals companies Tuesday, 14 Apr 2015 | 5:58 PM ET

    Baxter International Inc. rose$. 11 or. 2 percent, to $69.98. Bristol-Myers Squibb Co. rose$. 08 or. 1 percent, to $64.03. Eli Lilly& Co. fell$. 06 or. 1 percent, to $73.46.

  • Midday Glance: Pharmaceuticals companies Tuesday, 14 Apr 2015 | 1:34 PM ET

    Baxter International Inc. rose$. 02 or percent, to $69.89. Bristol-Myers Squibb Co. rose$. 28 or. 4 percent, to $64.23. Hospira rose$. 04 or percent, to $87.68.

  • FDA panel wants heart failure risk on AstraZeneca drugs Tuesday, 14 Apr 2015 | 12:56 PM ET

    WASHINGTON— Federal health advisers say AstraZeneca's Onglyza and a related diabetes drug should carry new information about a possible association with heart failure and death. The FDA convened Tuesday's meeting to review data from a 16,000- patient study looking at Onglyza and Kombiglize's heart safety. AstraZeneca's study did not show links to heart...

  • Early Glance: Pharmaceuticals companies Tuesday, 14 Apr 2015 | 10:42 AM ET

    Baxter International Inc. fell$. 13 or. 2 percent, to $69.74. Bristol-Myers Squibb Co. fell$. 24 or. 4 percent, to $63.71. Eli Lilly& Co. fell$. 27 or. 4 percent, to $73.25.

  • Why do drugs have such weird names? Friday, 10 Apr 2015 | 7:00 AM ET
    Pharmacist dispensing pills

    It can cost $75,000 to $250,000, and the names keep getting stranger as companies balance regulator concerns with the desire to market the product.